title: Drug companies look to biomarkers to salvage cancer target.
authors.forename: Elie
authors.initials: E
authors.lastname: Dolgin
mesh_terms: D054316:Biomarkers, Pharmacological; D002986:Clinical Trials as Topic; D055808:Drug Discovery / Q000639:trends*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017526:Receptor, IGF Type 1 / Q000037:antagonists & inhibitors*
chemical_list: D054316:Biomarkers, Pharmacological; D017526:Receptor, IGF Type 1